NCT04000529 2025-09-30Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected MalignanciesNovartisPhase 1 Terminated122 enrolled
NCT04152018 2025-05-28Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.PfizerPhase 1 Terminated85 enrolled
NCT04193293 2023-09-21A Study of Duvelisib in Combination With Pembrolizumab in Head and Neck CancerSecuraBioPhase 1/2 Terminated2 enrolled